Loyalhanna Care Center: Illegal Drug Doses - PA
Resident 8, who had cognitive impairment and required staff assistance for daily care, was given 0.50 milligrams of Ativan dozens of times between December 2025 and March 2026. The original physician's order from November 27, 2025, authorized the anti-anxiety drug only for 14 days.
No doctor extended that order. No physician documented why the resident needed the medication beyond two weeks.
The facility's own policy, dated January 1, 2026, required specific documentation for any PRN psychotropic medication use beyond 14 days. Orders extending beyond that timeframe needed written rationale from the prescribing physician and a specific duration.
Medication records showed Resident 8 received Ativan on December 2, 5, 6, 7, 9, 18, 19, 23, 24, and 27. The pattern continued in January with doses on the 2nd, 4th, 9th, 11th, 22nd, 24th, 25th, 28th, and 30th.
February brought more frequent administration: the 4th, 5th, 7th, 9th through 11th, 13th, 17th, 20th, 21st, and 23rd through 25th. March dosing occurred on the 2nd, 4th through 6th, 8th, 10th, 12th, 14th, 15th, and 18th through 21st, ending on the 23rd.
Each dose violated federal regulations designed to prevent unnecessary psychotropic medication use in nursing home residents. The drugs affect mental state, emotions, and behavior, making proper oversight critical for vulnerable populations like dementia patients.
The Director of Nursing confirmed the violation during an April 1 interview with inspectors. She acknowledged no physician's order existed to continue the as-needed Ativan beyond the initial 14-day authorization. She also confirmed no documented evidence existed from any physician or prescriber explaining why the medication should continue.
Resident 8's quarterly assessment from February 28, 2026, painted a picture of significant vulnerability. The resident had cognitive impairment, needed staff help with daily activities, and carried a dementia diagnosis. The assessment noted the resident was receiving anti-anxiety medication.
The facility administered Ativan for "restlessness/anxiety" according to the original November order. But without proper medical oversight, inspectors could not determine whether the continued dosing served the resident's actual needs or simply became routine practice.
Federal regulations require nursing homes to ensure medication regimens remain free from unnecessary psychotropic drugs. The rules recognize these medications' potential for harm, particularly among cognitively impaired residents who cannot advocate for themselves.
Loyalhanna Care Center's violation affected one of 35 residents reviewed during the inspection. Inspectors classified the harm level as minimal, but the finding reveals systemic problems with medication oversight and physician communication.
The facility's policy appeared comprehensive on paper. It required diagnosed conditions and documented indications for PRN psychotropic use. It set clear 14-day limits for most medications. It demanded physician rationale for any extensions.
But policy means nothing without implementation.
For four months, staff administered a controlled substance to a dementia patient without proper authorization. They followed expired orders. They ignored their own written procedures. They failed to obtain required physician documentation.
The violation continued through the facility's quarterly assessment process. Staff completed the February MDS evaluation noting the resident's anti-anxiety medication use, yet no one questioned whether proper orders existed for the ongoing Ativan administration.
Resident 8's case illustrates broader concerns about psychotropic medication oversight in nursing homes. Federal data shows these drugs are often used inappropriately to manage behavioral symptoms in dementia patients, sometimes causing more harm than benefit.
The inspection occurred on April 2, 2026, more than four months after the original 14-day order expired. By then, Resident 8 had received dozens of unauthorized doses of a medication that affects brain function and behavior.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Loyalhanna Care Center from 2026-04-02 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 15, 2026 · Our methodology
LOYALHANNA CARE CENTER in LATROBE, PA was cited for violations during a health inspection on April 2, 2026.
The original physician's order from November 27, 2025, authorized the anti-anxiety drug only for 14 days.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.
Frequently Asked Questions
- What happened at LOYALHANNA CARE CENTER?
- The original physician's order from November 27, 2025, authorized the anti-anxiety drug only for 14 days.
- How serious are these violations?
- Violation severity varies from minor documentation issues to serious safety concerns. Review the inspection report for specific deficiency codes and scope. All violations must be corrected within required timeframes and are subject to follow-up verification inspections.
- What should families do?
- Families should: (1) Ask facility administration about specific corrective actions taken, (2) Request to see the follow-up inspection report verifying corrections, (3) Check if this represents a pattern by reviewing prior inspection reports, (4) Compare this facility's ratings with other nursing homes in LATROBE, PA, (5) Report any new concerns directly to state authorities.
- Where can I see the full inspection report?
- The complete inspection report is available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request a copy directly from LOYALHANNA CARE CENTER or from the state Department of Health. The report includes specific deficiency codes, facility responses, and correction timelines. This facility's federal provider number is 395860.
- Has this facility had violations before?
- To check LOYALHANNA CARE CENTER's history, visit Medicare.gov's Care Compare and review their inspection history, quality ratings, and staffing levels. Look for patterns of repeated violations, especially in critical areas like abuse prevention, medication management, infection control, and resident safety.